Atom
Product
Blog
Pricing
Webinars
Sign in
Book Demo
Eligibility
Profile
Finance
Other
Similar Grants
Hereditary Hemorrhagic Telangiectasia (HHT) Center | Atom
Back
Hereditary Hemorrhagic Telangiectasia (HHT) Center
Forecasted Due Date: Jun 20, 2025
HHS-HRSA
Forecasted
Description
The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) program is to reduce morbidity and mortality associated with HHT by:
1) expanding access to and coordination of care for HHT patients; and 2) developing a de-identified, aggregate patient data registry to better understand this rare disease and treatment outcomes. MCHB
Estimated Total Program Funding
$1,800,000
Expected Number of Awards
1
Eligible Applicants
- Others
Additional Eligibility Information
Public Entities, Institutions of Higher Education, Tribes and Tribal Organizations, For-profit organizations, Small businesses, Nonprofits
Funding Type
Cooperative Agreement
Categories of Funding Activity
- Health
Opportunity Type
Discretionary
Grantor Contact Information
Nwilliams1@hrsa.gov Nordia Williams (240)475-3310
Grantor Email
nwilliams1@hrsa.gov
Start finding grants with Atom for
$0 today
$30 Billed monthly after 7-day trial. Cancel anytime.
Personalized grant emails delivered weekly, right to your inbox.
AI powered search engine with both keyword and semantic search capabilities.
Grant filters to find the perfect funding opportunities.
Get Started
Similar Grants
Academic Proposals
Rolling Submissions
CHDI Foundation
Health Equity Data Access Program (HEDAP)
Rolling Submissions
HHS-CMS
$90,000
Research Funding
Rolling Submissions
PTEN Research